Form 4: Orthofix Executive Sells Shares for Tax Obligations

Orthofix Medical Inc. President, Global Spine, Max Reinhardt, sold 1,643 shares of common stock on June 11, 2025, to cover tax withholding obligations related to restricted stock unit settlement.

Summary

• Max Reinhardt, President, Global Spine of Orthofix Medical Inc. (OFIX), reported a transaction involving company common stock.
• On June 11, 2025, Mr. Reinhardt sold 1,643 shares of Orthofix common stock at a price of $11.64 per share.
• The sale was a 'sell-to-cover' transaction, executed to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
• This transaction was pre-approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors, with no discretion exercised by Mr. Reinhardt.
• Following the reported transaction, Mr. Reinhardt beneficially owns 27,481 shares, which includes 24,324 previously reported restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale for tax purposes related to RSU settlement, which does not indicate a change in management's confidence or company performance.

Future Outlook

NA

Management Comments

• The sale was made without the exercise of any discretion by the reporting person.

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders: The sale represents a minor, routine transaction for tax purposes and is unlikely to have a significant impact on the company's share price or overall shareholder value.
• Employees, Customers, Suppliers, Creditors: No direct or material impact is expected from this routine insider transaction.

Key Dates

Keywords

Orthofix Medical Inc., OFIX, SEC Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Executive Compensation